Skip to main content
PMC home page
British Journal of Experimental Pathology logoLink to British Journal of Experimental Pathology
. 1974 Aug;55(4):363–373.

Vaccine Potencies of the Live Vaccine Strain of Francisella tularensis and Isolated Bacterial Components

P Hambleton, C G T Evans, A M Hood, R E Strange
PMCID: PMC2072650  PMID: 4215444

Abstract

The live vaccine strain of Francisella tularensis rapidly lost virulence (to mice) when grown under controlled conditions in the Porton mobile enclosed chemostat but protective activity was lost much less rapidly. In contrast, bacteria maintained their virulence and vaccine potency during batch culture in shaken flasks. Attempts to identify virulence and protective factors of F.tularensis were unsuccessful. The protective activities in mice of killed suspensions of F.tularensis, bacterial fractions and extracts of live bacteria were compared with the activity of live bacteria; all the non-living potential vaccines were ineffective.

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER M. M. A quantitative antibody response of man to infection or vaccination with Pasteurella tularensis. J Exp Med. 1950 Jul 1;92(1):51–57. doi: 10.1084/jem.92.1.51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BELL J. F., LARSON C. L., WICHT W. C., RITTER S. A. Studies on the immunization of white mice against infections with Bacterium tularense. J Immunol. 1952 Nov;69(5):515–524. [PubMed] [Google Scholar]
  3. BELTON F. C., STRANGE R. E. Studies on a protective antigen produced in vitro from Bacillus anthracis: medium and methods of production. Br J Exp Pathol. 1954 Apr;35(2):144–152. [PMC free article] [PubMed] [Google Scholar]
  4. Claflin J. L., Larson C. L. Infection-immunity in tularemia: specificity of cellular immunity. Infect Immun. 1972 Mar;5(3):311–318. doi: 10.1128/iai.5.3.311-318.1972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. DOWNS C. M., MOODY M. D. Studies on tularemia. II. The antigenic properties of variants of Pasteurella tularensis in various hosts. J Bacteriol. 1955 Sep;70(3):305–313. doi: 10.1128/jb.70.3.305-313.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. EIGELSBACH H. T., BRAUN W., HERRING R. D. Studies on the variation of Bacterium tularense. J Bacteriol. 1951 May;61(5):557–569. doi: 10.1128/jb.61.5.557-569.1951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. EIGELSBACH H. T., DOWNS C. M. Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J Immunol. 1961 Oct;87:415–425. [PubMed] [Google Scholar]
  8. Eigelsbach H. T., Hornick R. B., Tulis J. J. Recent studies on live tularemia vaccine. Med Ann Dist Columbia. 1967 May;36(5):282–286. [PubMed] [Google Scholar]
  9. Foshay L., Hesselbrock W. H., Wittenberg H. J., Rodenberg A. H. Vaccine Prophylaxis against Tularemia in Man. Am J Public Health Nations Health. 1942 Oct;32(10):1131–1145. doi: 10.2105/ajph.32.10.1131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Foshay L., Ruchman I., Nicholes P. S. ANTITULARENSE SERUM: CORRELATION BETWEEN PROTECTIVE CAPACITY FOR WHITE RATS AND PRECIPITABLE ANTIBODY CONTENT. J Clin Invest. 1947 Jul;26(4):756–760. doi: 10.1172/JCI101858. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. LARSON C. L., BELL J. F., OWEN C. R. The development of resistance in mice immunized with soluble antigen derived from Bacterium tularense. J Immunol. 1954 Oct;73(4):221–225. [PubMed] [Google Scholar]
  12. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  13. MOODY M. D., DOWNS C. M. Studies on tularemia. I. The relation between certain pathogenic and immunogenic properties of variants of Pasteurella tularensis. J Bacteriol. 1955 Sep;70(3):297–304. doi: 10.1128/jb.70.3.297-304.1955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. ORMSBEE R. A., BELL J. F., LARSON C. L. Studies on Bacterium tularense antigens. I. The isolation, purification, and biologic activity of antigen preparations from Bacterium tularense. J Immunol. 1955 May;74(5):351–358. [PubMed] [Google Scholar]
  15. ORMSBEE R. A., LARSON C. L. Studies on Bacterium tularense antigens. II. Chemical and physical characteristics of protective antigen preparations. J Immunol. 1955 May;74(5):359–370. [PubMed] [Google Scholar]
  16. Pirt S. J. The diffusion capsule, a novel device for the addition of a solute at a constant rate to a liquid medium. Its application to metabolic regulation. Biochem J. 1971 Jan;121(2):293–297. doi: 10.1042/bj1210293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Procházka O., Dubanská H. The antigenic structure of Francisella tularensis. I. Isolation of the ether antigen and its fractionation. Folia Microbiol (Praha) 1972;17(3):232–238. doi: 10.1007/BF02875819. [DOI] [PubMed] [Google Scholar]
  18. Procházka O., Dubanská H. The antigenic structure of Francisella tularensis. II. Fractionation of the ether antigen on cellulose carriers and by gel filtration. Folia Microbiol (Praha) 1972;17(4):300–307. doi: 10.1007/BF02880205. [DOI] [PubMed] [Google Scholar]
  19. Scharer J. M., Klein F., Lincoln R. E. Growth and metabolism of live vaccine strain of Pasteurella tularensis. Appl Microbiol. 1968 Jun;16(6):855–861. doi: 10.1128/am.16.6.855-861.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Strange R. E., Benbough J. E., Hambleton P., Martin K. L. Methods for the assessment of microbial populations recovered from enclosed aerosols. J Gen Microbiol. 1972 Aug;72(1):117–125. doi: 10.1099/00221287-72-1-117. [DOI] [PubMed] [Google Scholar]
  21. TRESSELT H. B., WARD M. K. BLOOD-FREE MEDIUM FOR THE RAPID GROWTH OF PASTEURELLA TULARENSIS. Appl Microbiol. 1964 Nov;12:504–507. doi: 10.1128/am.12.6.504-507.1964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. WRIGHT G. G., HEDBERG M. A., FEINBERG R. J. Studies on immunity in anthrax. II. In vitro elaboration of protective antigen by non-proteolytic mutants of Bacillus anthracis. J Exp Med. 1951 Jun;93(6):523–527. doi: 10.1084/jem.93.6.523. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Experimental Pathology are provided here courtesy of Wiley

RESOURCES